on SENSORION (EPA:ALSEN)
Sensorion to Participate in Stifel's Biotech Summer Summit
Montpellier, August 5, 2024, 7.30 am CET – Sensorion, a clinical-stage biotechnology company specializing in therapies for hearing loss, will participate in Stifel's Biotech Summer Summit 2024. The event will take place from August 12-14, 2024, in Newport, Rhode Island, USA.
Nawal Ouzren, Chief Executive Officer of Sensorion, will engage with investors to discuss the company’s strategic developments. Highlights include advancements in their gene therapy and small molecule programs.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SENSORION news